Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06825689 · ClinicalTrials.gov registry record · NA
Unidos Contra el VPH
A NA study of Cervical Cancers and Human Papilloma Virus (HPV), sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 735
- Enrollment target
- 1
- Study location
NCT06825689 is a NA study of Cervical Cancers and Human Papilloma Virus (HPV) that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 735 participants, above the 125-participant average among 3 other Cervical Cancers trials with a reported enrollment target (488% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06825689, a NA study of Cervical Cancers and Human Papilloma Virus (HPV), is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 735 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Unidos Contra el VPH study is to help find options to screen, or check, for cervical cancer that individuals can do at home to help prevent and detect cervical cancer early. Usually, people get screened for cervical cancer with a Pap smear and human papillomavirus (HPV) test by a health care provider. This is not always easy for individuals who are not able to get to a clinic or feel uncomfortable having the procedure done. That is why we want to find other ways that may be easier and more comfortable for people to be screened for cervical cancer. The two main questions the study aims to answer are: 1. How do the following three cervical cancer screening methods compare for improving screening completion rates? o In-home HPV self-sampling with a vaginal swab * In-home HPV self-sampling with urine testing * In-clinic traditional Pap smear with HPV test 2. What are participant beliefs and preferences regarding these three screening methods? Participants in the study will be randomly assigned to one of three groups. This means each person has an equal chance of being placed in any group. They will also complete two surveys as part of the study. The three screening method groups are described below: Group 1: Urine Self-Sampling * Participants in this group will receive a kit with a urine sample cup to use at home, instructions explaining how to take the sample and a pre-paid mailing box to mail the urine sample to the lab. Group 2: Vaginal Swab Self-Sampling o Participants in this group will receive a kit with a vaginal swab and collection tube to use at home, instructions explaining how to take the sample and a pre-paid mailing box to mail the sample to the lab. Group 3: In-Clinic Screening * An in-clinic co-testing appointment is scheduled for a Pap smear and HPV test done together at Project Vida Health Center. By comparing these approaches, this study aims to improve access to cervical cancer screening and pro
Conditions Studied
Interventions
- DEVICE Self-sampling with urine
- DEVICE Self-sampling with swab
- DEVICE In-clinic Pap/HPV co-testing
Study Locations (1)
Texas
- Project Vida Health Center - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 735 participants |
| Start Date | 2025-01-28 |
| Est. Completion | 2029-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06825689
The ClinicalTrials.gov registry entry for NCT06825689 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 735 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 125-participant average among 3 other Cervical Cancers trials with a reported enrollment target (488% higher). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Cancers appearing as the primary indexed condition, and to 3 interventions - of which Self-sampling with urine is the first listed.
NCT06825689 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06825689 about?
NCT06825689 is a clinical study titled "Unidos Contra el VPH". The purpose of the Unidos Contra el VPH study is to help find options to screen, or check, for cervical cancer that individuals can do at home to help prevent and detect cervical cancer early. Usually, people get screened for cervical cancer with a Pap smear and human papillomavirus (HPV) test by a ...
What is the current status of trial NCT06825689?
This trial is currently recruiting. It is a NA study. The enrollment target is 735 participants. The study started on 2025-01-28. Estimated completion is 2029-02.
What conditions does trial NCT06825689 study?
This clinical trial studies the following conditions: Cervical Cancers, Human Papilloma Virus (HPV).
What interventions are being tested in trial NCT06825689?
The interventions under investigation include: Self-sampling with urine (DEVICE), Self-sampling with swab (DEVICE), In-clinic Pap/HPV co-testing (DEVICE).
Who is sponsoring clinical trial NCT06825689?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06825689 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
ACTIVE NOT RECRUITING · NA
-
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
RECRUITING · Phase 2
-
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.